---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-000821"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:42:19.668632+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Mesa Laboratories appoints Mark Capone to Board of Directors

## Summary
- Board expanded from 6 to 7 members; Capone appointed effective Jan 5, 2024.
- Capone most recently served as CEO/President of Myriad Genetics; also 17 yrs at Eli Lilly.
- Appointed to Audit Committee, replacing Shiraz Ladiwala.
- Capone determined independent under Nasdaq and SEC rules.
- No related party transactions with Mesa reported.

## SEC filing metadata
- accession: 0001437749-24-000821
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774924000821/0001437749-24-000821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774924000821/mlab20240103_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-000821
- JSON: https://secwatch.observer/filing/0001437749-24-000821.json
- Plain text: https://secwatch.observer/filing/0001437749-24-000821.txt

## Key facts
- Executive change
  Mark Capone was appointed as Director at MESA LABORATORIES INC /CO/.
  - Action: appointed
  - Role: Director
  source text: Effective January 5, 2024, the Board of Directors (“Board”) of Mesa Laboratories, Inc. (“Mesa ”), upon the recommendation of its Nominating and Governance Committee, voted to expand the size of the Board from six to seven members, and to appoint Mark Capone to fill the newly created seat.
  evidence_url: https://www.sec.gov/Archives/edgar/data/724004/000143774924000821/0001437749-24-000821-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.